XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.19.1

Stockholder's Equity | 3 Months Ended
--- | ---
Feb. 28, 2019
Equity [Abstract] |
Stockholder's Equity | Note 8 – Stockholder’s Equity The Company maintains the 2006 Stock Incentive Plan (the “2006 Plan”) under which it has reserved 1,000,000 shares of the Company’s common stock for issuance pursuant to stock options, restricted stock, stock-appreciation rights (commonly referred to as “SARs”) and stock awards (i.e. performance options to purchase shares and performance units). As of February 28, 2019 and November 30, 2018, there were 372,500 and 380,000 options issued, but not yet exercised, under the 2006 Plan, respectively. As of February 28, 2019, there were 0 shares available for future issuance under the 2006 Plan. The Company maintains the 2012 Equity Incentive Plan (the “2012 Plan”) which became effective December 1, 2011 as approved by the Board of Directors and approved by the stockholders at the 2012 Annual Meeting on July 10, 2012. The 2012 Plan originally reserved 1,500,000 shares of the Company’s common stock for issuance pursuant to stock options, restricted stock, SARs, and other stock awards (i.e. performance shares and performance units). In May 2012, the Board of Directors approved an amendment to the 2012 Plan to increase the number of shares of the Company’s common stock reserved for issuance to 2,500,000 shares. As of February 28, 2019, there were 621,365 service-based options issued, 129,729 service-based restricted common shares granted, 823,415 performance-based and 116,240 market-based restricted common shares granted under the 2012 Plan. As of February 28, 2019, there were 0 shares available for future issuance under the 2012 Plan. In March 2018, the Company received notice that shares of the Company’s common stock issued to certain executive officers pursuant to the Company’s 2012 Stock Incentive Plan had purportedly been issued in excess of the shares reserved for issuance under the Plan. The Company has established an independent committee of the Board of Directors to review this issue. Service-based vesting condition options The fair value of each option award is estimated on the date of the grant using the Black-Scholes valuation model that uses the assumptions noted in the following table. Expected volatility is based on the historical volatility of the Company’s stock over the most recent period commensurate with the expected life of the Company’s stock options. The Company uses historical data to estimate option exercise and employee termination within the valuation model. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The expected term of options granted to employees is calculated, in accordance with the “simplified method” for “plain vanilla” stock options allowed under GAAP. Expected dividends are based on the historical trend of the Company not issuing dividends. There were no options granted during the three months ended February 28, 2019 and February 28, 2018, respectively. Stock option activity for the three months ended February 28, 2019, was as follows:
|  |  |  |  | Weighted |  |  | Weighted Average |  |  |  |
|  |  |  |  | Average |  |  | Remaining |  |  | Aggregate |
|  | Options |  |  | Exercise Price |  |  | Contractual Life (Years) |  |  | Intrinsic Value |
Outstanding at November 30, 2018 |  |  | 1,001,365 |  |  | $ | 2.77 |  |  |  | 3.97 |  |  | $ | 4,580,967 |
Granted |  |  | — |  |  |  | — |  |  |  |  |  |  |  | — |
Exercised |  |  | (2,500 | ) |  |  | 2.28 |  |  |  |  |  |  |  | 14,175 |
Expired/forfeited |  |  | (5,000 | ) |  |  | 2.23 |  |  |  |  |  |  |  | 21,625 |
Outstanding at February 28, 2019 |  |  | 993,865 |  |  | $ | 2.78 |  |  |  | 3.75 |  |  | $ | 3,827,501 |
Exercisable at February 28, 2019 |  |  | 970,821 |  |  | $ | 2.68 |  |  |  | 3.73 |  |  | $ | 3,813,041 |
The aggregate intrinsic value represents the total value of the difference between the Company’s closing stock price on the last trading day of the period and the exercise price of the options, multiplied by the number of in-the-money stock options that would have been received by the option holders had all option holders exercised their options on either February 28, 2019 or November 30, 2018, as applicable. The intrinsic value of the Company’s stock options changes based on the closing price of the Company’s stock. For the three months ended February 28, 2019, the Company issued 2,500 common shares to an option holder who exercised options for $5,700. For the three months ended February 28, 2018, the Company issued 1,250 common shares to option holders who exercised options for $2,250. Significant option groups exercisable at February 28, 2019 and related price and contractual life information are as follows:
|  | Outstanding |  |  | Exercisable |
|  |  |  |  | Weighted Average |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Remaining |  |  | Weighted |  |  |  |  |  | Weighted |
Range of Exercise Prices |  | Outstanding |  |  | Contractual Life (Years) |  |  | Average Exercise Price |  |  | Outstanding |  |  | Average Exercise Price |
$1.01 to $2.00 |  |  | 422,500 |  |  |  | 2.69 |  |  | $ | 1.73 |  |  |  | 422,500 |  |  | $ | 1.73 |
$2.01 to $3.00 |  |  | 267,500 |  |  |  | 2.13 |  |  | $ | 2.72 |  |  |  | 267,500 |  |  | $ | 2.72 |
$3.01 to $4.00 |  |  | 227,229 |  |  |  | 6.92 |  |  | $ | 3.18 |  |  |  | 223,062 |  |  | $ | 3.18 |
$6.01 to $7.00 |  |  | 25,000 |  |  |  | 8.09 |  |  | $ | 6.95 |  |  |  | 23,334 |  |  | $ | 6.98 |
$7.01 to $8.00 |  |  | 51,636 |  |  |  | 4.83 |  |  | $ | 7.85 |  |  |  | 34,425 |  |  | $ | 7.85 |
|  |  | 993,865 |  |  |  | 3.75 |  |  | $ | 2.78 |  |  |  | 970,821 |  |  | $ | 2.68 |
A summary of the status of the Company’s non-vested options as of February 28, 2019, and changes during the three months ended February 28, 2019, is presented below:
|  |  |  |  | Weighted Average |
|  |  |  |  | Grant-Date |
|  | Options |  |  | Fair Value |
Non-vested at November 30, 2018 |  |  | 40,254 |  |  | $ | 3.06 |
Granted |  |  | — |  |  |  | — |
Vested |  |  | (17,210 | ) |  |  | 3.23 |
Forfeited |  |  | — |  |  |  | — |
Non-vested at February 28, 2019 |  |  | 23,044 |  |  | $ | 2.94 |
As of February 28, 2019 there was approximately $57,000 of total unrecognized compensation cost related to non-vested service related share-based compensation arrangements granted under the 2006 Plan and the 2012 Plan. The cost is expected to be recognized over a weighted-average period of .77 years as of February 28, 2019. The total fair value of shares vested during the three months ended February 28, 2019 was approximately $56,000. Performance and market-based vesting condition options Per the 2018 Employment Agreements, based upon certain performance criteria, the Company shall grant David Portnoy and Mark Portnoy a percentage of up to 47,273 and 40,000, respectively, of qualified stock options of the Company’s common stock. For market-based vesting condition options, accounting principles do not require that the market condition be met in order for the compensation cost to be recognized. Fair value of these options has been determined using a Monte Carlo valuation approach and is being recognized over the requisite service period, regardless if the market condition will be met. During fiscal 2019, 15,756 and 13,332, respectively, of qualified stock options will be expensed over the requisite service period. The fair value of these options as of February 28, 2019 was approximately $45,000 and is reflected as selling, general and administrative expenses in the accompanying consolidated statement of comprehensive income (loss). For performance-based vesting condition options, the Company estimated the fair value of the qualified stock options that met certain performance targets by the end of the fiscal 2018 requisite service period using a Black-Scholes valuation model. The total estimated fair value of 26,243 and 22,222 of qualified stock options, respectively, was approximately $140,000. The remaining fair value of these options as of February 28, 2019 was approximately $45,000 and is reflected as selling, general and administrative expenses in the accompanying consolidated statement of comprehensive income (loss). Per the Amendment Agreement, based upon certain performance criteria, the Company shall grant Oleg Mikulinsky a percentage of up to 8,000 of qualified stock options of the Company’s common stock. For market-based vesting condition options, accounting principles do not require that the market condition be met in order for the compensation cost to be recognized. Fair value of these options has been determined using a Monte Carlo valuation approach and is being recognized over the requisite service period, regardless if the market condition will be met. During fiscal 2019, 2,666, of qualified stock options will be expensed over the requisite service period. The fair value of these options as of February 28, 2019 was approximately $4,800 and is reflected as selling, general and administrative expenses in the accompanying consolidated statement of comprehensive income (loss). For performance-based vesting condition options, the Company estimated the fair value of the qualified stock options that met certain performance targets by the end of the requisite service period using a Black-Scholes valuation model. The total estimated fair value of 4,444 of qualified stock options was approximately $13,600. The remaining fair value of these options as of February 28, 2019 was approximately $4,300 and is reflected as selling, general and administrative expenses in the accompanying consolidated statement of comprehensive income (loss). There were no performance-based or market-based vesting condition options granted during the three months ended February 28, 2018. Restricted common shares As of April 15, 2016, the Company entered into Amended and Restated Employment Agreements (“Employment Agreements”) with each of the Company’s Co-CEOs. The Employment Agreements provide for the grant of shares of the Company’s common stock based on certain performance measures being attained by each of the Company’s Co-CEOs during fiscal year 2016 and fiscal year 2017. The Employment Agreements state if David Portnoy and Mark Portnoy are employed by the Company on November 30, 2016 and November 30, 2017, then no later than February 28, 2017 and February 28, 2018, respectively, the Company will grant up to 186,487 and 162,163 shares of common stock for each fiscal year. Based upon the performance measures attained as of November 30, 2016, the Company granted 183,145 and 159,257 shares of common stock to David Portnoy and Mark Portnoy, respectively. There was $0 of total unrecognized compensation cost as of February 28, 2019 and February 28, 2018, respectively. Based upon the performance measures being attained as of November 30, 2017, the Company granted a total of 121,801 and 105,915 shares of common stock to David Portnoy and Mark Portnoy, respectively. The fair value of the shares granted was approximately $1,200,000. There was $0 and $496,000, respectively, remaining to be recognized and is reflected as selling, general and administrative expense in the accompanying consolidated statements of comprehensive income (loss) as of February 28, 2019 and February 28, 2018, respectively. As of April 18, 2016, the Company entered into a second Amendment Agreement (the “Amendment”), with the Company’s CIO Oleg Mikulinsky effective December 1, 2015, amending certain terms of the Amendment Agreement dated May 1, 2013 and Mikulinsky Employment Agreement dated March 5, 2012. The Amendment provides for the grant of shares of the Company’s common stock based on certain performance measures being attained by the Company during fiscal year 2016 and fiscal year 2017. The Amendment states if Executive is employed by the Company on November 30, 2016 and November 30, 2017, then no later than February 28, 2017 and February 28, 2018, respectively, the Company will grant Executive up to 20,000 shares of restricted stock based on performance as set forth in the Amendment per each fiscal year. Based upon performance measures being attained as of November 30, 2016, the Company granted 19,620 shares of common stock to Oleg Mikulinksy. There was $0 of total unrecognized compensation cost as of February 28, 2019 and February 28, 2018. Based upon performance measures being attained as of November 30, 2017, the Company will grant a total of 14,729 shares of common stock to Oleg Mikulinksy. The fair value of the shares to be granted is approximately $80,000. There was $0 and $40,000, respectively, remaining to be recognized and is reflected as selling, general and administrative expense in the accompanying consolidated statements of comprehensive income (loss) as of February 28, 2019 and February 28, 2018, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration